Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research

Exogenous stem cell therapy (SCT) has been recognized recently as a promising neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem cells (MSCs) are the primary source of stem cells used in the majority of both pre-clinical and clinical studies in stroke. In the absenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Haiqing, Zhang, Bin, Chhatbar, Pratik Y., Dong, Yi, Alawieh, Ali, Lowe, Forrest, Hu, Xiquan, Feng, Wuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300779/
https://www.ncbi.nlm.nih.gov/pubmed/30343609
http://dx.doi.org/10.1177/0963689718806846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300779/
https://www.ncbi.nlm.nih.gov/pubmed/30343609
http://dx.doi.org/10.1177/0963689718806846

Ejemplares similares